Daniel Sajkowski Sells 2,000 Shares of Calumet (NASDAQ:CLMT) Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 2,000 shares of the business’s stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $15.77, for a total transaction of $31,540.00. Following the completion of the sale, the director directly owned 82,237 shares of the company’s stock, valued at $1,296,877.49. The trade was a 2.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Calumet Stock Performance

Shares of CLMT stock opened at $26.96 on Friday. The stock has a market capitalization of $2.34 billion, a price-to-earnings ratio of -62.70 and a beta of 1.24. Calumet, Inc. has a one year low of $7.68 and a one year high of $30.35. The company’s 50-day simple moving average is $23.06 and its 200-day simple moving average is $19.91.

Calumet (NASDAQ:CLMT) last released its earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The firm had revenue of ($3,098.50) million for the quarter, compared to the consensus estimate of $1.04 billion. The company’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the business earned ($0.47) EPS. As a group, research analysts forecast that Calumet, Inc. will post -3.02 EPS for the current year.

Institutional Trading of Calumet

Several hedge funds have recently bought and sold shares of the company. Islay Capital Management LLC acquired a new position in Calumet during the 4th quarter valued at about $25,000. Aster Capital Management DIFC Ltd grew its holdings in Calumet by 294.7% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock worth $33,000 after buying an additional 1,229 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in Calumet in the 4th quarter valued at approximately $34,000. Amalgamated Bank bought a new stake in Calumet during the 2nd quarter valued at $37,000. Finally, Covestor Ltd boosted its position in Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 492 shares during the period. 34.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CLMT has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. The Goldman Sachs Group lifted their price target on shares of Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a report on Friday, January 30th. Wall Street Zen lowered shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. UBS Group reissued a “neutral” rating and issued a $26.00 target price on shares of Calumet in a report on Friday, February 13th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $33.00 target price on shares of Calumet in a report on Monday, November 10th. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $22.83.

More Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Q4 2025 Results
• Positive Sentiment: FY2025 operational / cash‑flow improvements — management highlighted Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, ~ $100M of cost savings driving free cash flow, and a Montana Renewables expansion on track for Q2 2026; these items materially lower financial risk and support valuation upside longer term. FY2025 Results & Commentary
• Neutral Sentiment: Analyst / preview coverage mixed — several firms updated targets and ratings (Goldman raised its PT; others remain hold/neutral), and the consensus price target (~$22.83) is below the recent trading level, leaving sentiment conflicted. Analyst Coverage Summary
• Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (including a recent 2,000‑share tranche and several 20k tranches earlier), materially trimming his stake; visible insider sales often weigh on investor confidence. Insider Trades Report
• Negative Sentiment: Rising short interest — short positions climbed in February to roughly 6.97M shares (~8.4% of float) with a ~4.4 days‑to‑cover, increasing the potential for continued selling pressure and intraday volatility. Short Interest Data

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.